Technology News Ethics, Regulation, and Responsible Use

AI scribes: Efficiency for whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

March 12, 2026 By Kathryn Wighton 3 min read
Share

5 Key Takeaways

  • 1

    AI scribes are being rapidly adopted in US healthcare to alleviate documentation burdens, but their implementation lacks empirical evaluation.

  • 2

    Uncorrected inaccuracies in AI-generated notes can compromise patient safety, therapeutic efficacy, and trust in healthcare.

  • 3

    AI scribes struggle to capture nuances of human communication, raising concerns about bias and ableism in sensitive clinical contexts.

  • 4

    Privacy risks are heightened by cloud-based storage and third-party involvement, with inadequate consent processes for patients.

  • 5

    The authors advocate for regulatory approval and standardized performance metrics to ensure the safe and effective use of AI scribes.

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.

Related Content